Feed CRON
CR

Cronos Group Inc.

CRON · NASDAQ

$3.38 -1.17% (-$0.04)
1M +0.30%
Market Cap $1.25B
P/E Ratio 17.88x
Div. Yield -
ROE 6.46%

Bulios Fair Price

$2.86

15.4% downside

Trenutna cena

$3.38

Podcenjeno Poštena vrednost Precenjeno

Po podatkih Bulios Fair Price je delnica CRON trenutno precenjena glede na svojo tržno ceno. Kako deluje?

Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?

Analiza

AI poročilo o poslu, financah, vrednotenju, razpoloženju, novicah in tveganjih - napisano v nekaj minutah.

Piotroski F-Score Moderate
4/9
Valuation
43 /100
Fair
P/E 17.88x
EV/EBITDA 32.11x
P/S 5.14x
Growth
82 /100
Growing
Rev. growth 30.63%
Book val. growth 1.48%
EPS growth N/A
Profitability
69 /100
Strong
Gross margin 33.54%
Net margin 28.74%
Op. margin 5.12%
Quality
20 /100
Poor
ROIC 1.28%
ROE 6.46%
ROA 5.91%
Debt
100 /100
Low
Debt/Equity 0.00x
Current ratio 16.18x
Net debt/EBITDA -19.12x
Stability
22 /100
Unstable
Beta 1.28x
Rev. volatility 31.95%
EPS volatility 141.97%

Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več

Vprašajte StockBota o CRON
Online

O podjetju

Cronos Group Inc. (CRON) is a Canadian company operating in the legal cannabis industry and cannabis-based products. The company specializes in cultivating and producing cannabis for medical and recreational purposes. Cronos Group has a global presence and operates in several countries where cannabis and its products are legal. The company offers a wide range of products, including dried cannabis, oils, tinctures, vaporizer cartridges, and other consumer products based on cannabis. Cronos Group Inc. closely monitors regulations and laws related to legal cannabis in various countries and strives to maintain the highest standards of quality and safety for its products. Shares of Cronos Group Inc. (CRON) can present an interesting investment opportunity for investors following the growing market of legal cannabis and its products.

V vašem jeziku še ni na voljo, zato je besedilo v angleščini.

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

CEO

Michael Ryan Gorenstein

Employees

610

Headquarters

Stayner

Prihajajoči dogodki

05 NOV.

Earnings

Upcoming earnings report

36d

Uporabljamo nujne piškotke za delovanje spletnega mesta in izbirne analitične piškotke za merjenje uporabe. Preberite naš Pravilnik o zasebnosti.